Your session is about to expire
← Back to Search
TRE + Exercise for Weight Management
N/A
Recruiting
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adults with obesity (BMI between 30-50kg/m2)
Sedentary or lightly active (<7,500 steps/day)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from week 1 to week 12
Awards & highlights
Study Summary
This trial will examine the effect of time restricted eating (TRE) combined with either resistance training or aerobic training on body weight, body composition, metabolic disease risk, and cognition in adults over age 50.
Who is the study for?
This trial is for adults aged 50-85 with prediabetes and obesity (BMI of 30-50), who are sedentary or lightly active. It's not for shift workers, those with eating disorders, major cognitive impairments, smokers, people unable to report diet or activity accurately, those not weight stable recently, diagnosed with diabetes (T1DM/T2DM), mobility issues, or on weight/glucose control drugs.Check my eligibility
What is being tested?
The study tests time restricted eating (TRE) combined with either resistance training or aerobic exercise in older adults. TRE involves an eating window of 8-10 hours without calorie counting. The goal is to see if this leads to weight loss, better body composition, improved insulin sensitivity and cognition.See study design
What are the potential side effects?
Potential side effects may include hunger during fasting periods and fatigue due to changes in diet and new exercise routines. Muscle soreness from resistance training and the usual risks associated with aerobic exercises could also occur.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My BMI is between 30 and 50.
Select...
I am mostly inactive or lightly active, walking less than 7,500 steps a day.
Select...
My blood sugar levels indicate I have pre-diabetes.
Select...
I am between 50 and 85 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from week 1 to week 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from week 1 to week 12
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Lean mass
Secondary outcome measures
Attention
HbA1c
Insulin
+6 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TRE+RTExperimental Treatment1 Intervention
Participants will confine eating between either 10am-6pm or 12-8pm and fast from 6pm-10am or 8pm-12pm daily combined with 3-4 days of supervised resistance training per week.
Group II: TRE+ATActive Control1 Intervention
Participants will confine eating between either 10am-6pm or 12-8pm and fast from 6pm-10am or 8pm-12pm daily combined with 3-4 days of supervised aerobic training per week.
Find a Location
Who is running the clinical trial?
University of Illinois at ChicagoLead Sponsor
609 Previous Clinical Trials
1,559,269 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am taking medication to manage my weight or blood sugar.My BMI is between 30 and 50.I am mostly inactive or lightly active, walking less than 7,500 steps a day.My blood sugar levels indicate I have pre-diabetes.You can't accurately tell the study team about what you eat or how active you are.I cannot exercise for 40-60 minutes 3-4 days a week due to mobility issues.You have a history of eating disorders.I have a condition affecting my thinking, such as a brain injury or major psychiatric disorder.I am between 50 and 85 years old.I have been diagnosed with diabetes based on my blood sugar or HbA1c levels.People who smoke.You have gained or lost more than 4 kilograms (about 9 pounds) in the past 3 months.People who work night shifts or irregular hours.
Research Study Groups:
This trial has the following groups:- Group 1: TRE+RT
- Group 2: TRE+AT
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research enrolling geriatric participants?
"This clinical trial has specified that the eligible participant age range is between 50 and 85 years old."
Answered by AI
Are any new participants able to join this research project?
"Clinicaltrials.gov has revealed that this study is not currently looking to enroll individuals, as the last update was made on March 31st 2022. Nonetheless, there are 768 other medical trials which have openings for participants right now."
Answered by AI
Is participating in this experiment an option for me?
"This experiment is searching for 40 people with dysfunctional glucose metabolism, aged 50 to 85. To be considered, they must also have a Body Mass Index (BMI) between 25 and 50kg/m2; pre-diabetes levels of fasting blood sugar 100-125 mg/dl or HBA1c 5.7%-6.4% or OGTT ≥ 200 mg/dl); and have sedentary or lightly active lifestyles (<7,500 steps/day)."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger